Stryker's Matrix detachable coil devices proved to be as effective as GDC detachable coils in treating ruptured and unruptured aneurysms, according to a clinical trial presented at the Society of NeuroInterventional Surgery's annual meeting. The study also found that Matrix coils had a lower rate of aneurysm recurrence than GDC coils. Stryker purchased the device from Boston Scientific earlier this year.

Related Summaries